Editorial Open Access
Copyright ©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Sep 21, 2013; 19(35): 5769-5774
Published online Sep 21, 2013. doi: 10.3748/wjg.v19.i35.5769
Immunoglobulin G4-related gastrointestinal diseases, are they immunoglobulin G4-related diseases?
Satomi Koizumi, Terumi Kamisawa, Sawako Kuruma, Taku Tabata, Kazuro Chiba, Susumu Iwasaki, Yuka Endo, Go Kuwata, Koichi Koizumi, Department of Internal Medicine, Tokyo Metropolitan Komagome Hospital, Tokyo 113-8677, Japan
Tooru Shimosegawa, Division of Gastroenterology, Tohoku University, Sendai 980-8574, Japan
Kazuichi Okazaki, Department of Gastroenterology and Hepatology, Kansai Medical University, Hirakata 573-1191, Japan
Tsutomu Chiba, Department of Gastroenterology, Kyoto University, Kyoto 606-8507, Japan
Author contributions: Koizumi S and Kamisawa T contributed equally to this work, analyzed the data and wrote the manuscript; Kuruma S, Tabata T, Chiba K, Iwasaki S, Endo Y, Kuwata G and Koizumi K searched the literature; Shimosegawa T, Okazaki K and Chiba T evaluated and edited the manuscript.
Supported by Health and Labour Sciences Research Grants for Research on Intractable diseases (Research on IgG4-related disease) from Ministry of Health, Labour and Welfare of Japan
Correspondence to: Terumi Kamisawa, MD, PhD, Department of Internal Medicine, Tokyo Metropolitan Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8677, Japan. kamisawa@cick.jp
Telephone: +81-3-38232101 Fax: +81-3-38241552
Received: April 11, 2013
Revised: June 15, 2013
Accepted: July 18, 2013
Published online: September 21, 2013

Abstract

In immunoglobulin G4 (IgG4)-related disease (RD), organ enlargement or nodular lesions consisting of abundant infiltration of lymphocytes and IgG4-positive plasma cells and fibrosis are seen in various organs. Although infiltration of many IgG4-positive plasma cells is detected in the gastric and colonic mucosa and major duodenal papilla of patients with autoimmune pancreatitis, it cannot be diagnosed as a gastrointestinal lesion involved in IgG4-RD, because none of the following is observed in these lesions: a mass-like formation; dense fibrosis; or obliterative phlebitis. Based on our review of the literature, there appear to be two types of IgG4-related gastrointestinal disease. One is a gastrointestinal lesion showing marked thickening of the wall of the esophagus and stomach, consisting of dense fibrosis with abundant infiltration of IgG4-positive plasma cells, which usually show submucosal spreading. The other is an IgG4-related pseudotumor occurring in gastrointestinal regions such as the stomach, colon, and major duodenal papilla, showing polypoid or mass-like lesions. Most solitary IgG4-related gastrointestinal lesions that are not associated with other IgG4-RD appear to be difficult to diagnose. It is of utmost importance to rule out malignancy. However, these lesions may respond to steroid therapy. To avoid unnecessary resection, IgG4-related gastrointestinal diseases should be considered in the differential diagnosis.

Key Words: Immunoglobulin G4, Autoimmune pancreatitis, Gastritis, Colonic polyp, Ulcerative colitis

Core tip: Although the concept of immunoglobulin G4 (IgG4)-related gastrointestinal disease remains unclear, there appear to be two types of IgG4-related gastrointestinal disease. One is a gastrointestinal lesion showing marked thickening of the wall of the esophagus and stomach, consisting of dense fibrosis with abundant infiltration of IgG4-positive plasma cells, which usually show submucosal spreading. The other is an IgG4-related pseudotumor occurring in gastrointestinal regions such as the stomach, colon, and major duodenal papilla, showing polypoid or mass-like lesions. It is of utmost importance to rule out malignancy. To avoid unnecessary resection, IgG4-related gastrointestinal diseases should be considered in the differential diagnosis.



INTRODUCTION

Immunoglobulin G4 (IgG4)-related disease (RD) is a recently recognized systemic condition characterized by elevated serum IgG4 levels and steroid responsiveness. IgG4-RD shows organ enlargement or nodular lesions consisting of abundant infiltration of lymphocytes and IgG4-positive plasma cells and fibrosis. IgG4-RD affects various organs such as the pancreas, bile duct, gallbladder, liver, salivary gland, lacrimal gland, retroperitoneum, and lymph nodes simultaneously or metachronously. IgG4-RD frequently presents both clinically and radiologically with findings that mimic a malignancy, resulting in unnecessary resection[1-4]. According to comprehensive clinical diagnostic criteria for IgG4-RD[4], IgG4-RD is diagnosed when there is a characteristic diffuse/localized swelling or mass in a single or multiple organs with elevated serum IgG4 levels, or there are histological findings of abundant infiltration of IgG4-positive plasma cells and lymphocytes, along with fibrosis.

Autoimmune pancreatitis (AIP) is a typical lesion of IgG4-RD, and the concept of IgG4-RD was proposed based on research on AIP[1,2]. Although it has been reported that infiltration of many IgG4-positive plasma cells was observed in the gastric mucosa, colonic mucosa, and major duodenal papillae of some AIP patients[5-10], it is questionable whether they are the lesions involved in IgG4-RD. To clarify IgG4-related gastrointestinal disease, this article reviews the published literature about the relationships between IgG4 and gastrointestinal diseases such as esophagitis, gastritis, colitis, and duodenal papillitis with abundant infiltration of IgG4-positive plasma cells. A PubMed database search, from 1990 to April, 2013, using the terms “autoimmune pancreatitis or IgG4-related” and “esophagus, duodenum, papilla, colon” identified 116 papers. Additional sources were identified by scanning the bibliographies of original and review articles.

IGG4-RELATED ESOPHAGEAL LESIONS

There have been two case reports of IgG4-related esophagitis[11,12]. In both cases, esophageal stricture with thickening of the esophageal wall evoked debilitating dysphagia and weight loss. Endoscopy showed esophageal stricture without a cancerous lesion. With a diagnosis of gastrointestinal stromal tumor based on endoscopic ultrasound-guided fine needle aspiration (one case) and because of concerns regarding a hidden malignancy (one case), esophageal resection was performed in both patients. On gross examination, the resected specimens showed an esophageal submucosal stricture with mucosal ulceration and wall thickening; histologically, they showed transmural chronic fibrotic inflammation with abundant infiltration of IgG4-positive plasma cells and lymphocytes and phlebitis. There was no evidence of other IgG4-RD. The post-operative serum IgG4 level was 138 mg/dL in one case. Both lesions are considered esophageal manifestations of IgG4-RD and should be called IgG4-related esophagitis. These lesions would probably respond to steroid therapy. Thus, IgG4-related esophagitis should be kept in mind in the differential diagnosis of unexplained esophagitis with stricture.

IGG4-RELATED GASTRIC LESIONS

It has been reported that infiltration of many IgG4-positive plasma cells was observed in the gastric mucosa in 33%-47% of AIP patients[10,13]. Shinji et al[14] and Uehara et al[15] also reported that IgG4-positive plasma cells were significantly more abundant in the gastric mucosa of AIP patients. Most of the infiltrated IgG4-positive plasma cells in the gastric mucosa disappeared in the biopsy specimen from the gastric mucosa after steroid therapy[16]. However, neither dense fibrosis nor obliterative phlebitis was observed in the gastric mucosa of AIP patients. Baez et al[17] reported a patient with AIP and IgG4-related sialadenitis who showed diffusely thickened (up to 1.4 cm) and nodular gastric mucosa with abundant infiltration of IgG4-positive plasma cells. The patient’s serum IgG4 level was within the normal range (58 mg/dL), but the gastric lesion improved after steroid therapy. Kaji et al[18] reported an AIP patient (IgG4 level, 595 mg/dL) with multiple sporadic polyps in the gastric body with erosion and redness on the surface containing many infiltrated IgG4-positive plasma cells. On the other hand, two 3-cm-sized submucosal tumors that were laparoscopically wedge-resected showed histological findings of storiform fibrosis with abundant infiltration of lymphocytes and IgG4-positive cells (> 50/hpf), and they were reported as IGg4-related inflammatory pseudotumor of the stomach[19]. Both cases showed normal serum IgG4 levels and no evidence of other IgG4-RD[19]. Rollins et al[20] also reported a laparoscopically resected 5.6-cm IgG4-related fibrosclerosing pseudotumor of the stomach. Three cases with well-circumscribed, sclerosing nodular lesions of the stomach composed of fibrous tissue with abundant infiltration of IgG4-positive plasma cells were reported, and they were not associated with other IgG4-RD[21,22]. Fujita et al[23] reported a case with refractory gastric ulcers that worsened after successful Helicobacter pylori eradication therapy. The biopsy specimens taken from the ulcers showed abundant infiltration of IgG4-positive plasma cells (50/hpf). The patient’s serum IgG4 level was elevated to 203 mg/dL, but he had no other IgG4-RD.

Bateman et al[24] reported a case of intractable gastric ulcer showing storiform fibrosis and abundant infiltration of IgG4-positive plasma cells (> 100/hpf). These reported lesions are considered IgG4-related gastric lesions. Anjiki et al[25] reported that gastric emptying assessed by the carbon 13 acetate breath test was impaired in AIP patients and improved to the reference range after steroid therapy, and they suggested that the stomach might be a target organ of IgG4-RD.

IGG4-RELATED MAJOR DUODENAL PAPILLARY LESIONS

It has been reported that the duodenal major papilla is swollen in 41%-65% of AIP patients[26-28]. Abundant infiltration of IgG4-positive plasma cells is reportedly detected in 55%-80% of AIP patients[8,10,26,27]. Both a swollen major papilla and abundant infiltration of IgG4-positive plasma cells have shown improvement after steroid therapy[8,29]. In the resected pancreas of AIP patients, lymphoplasmacytic inflammation with many IgG4-positive plasma cells was detected in the major duodenal papilla connected to the head of the pancreas; thus, IgG4 immunostaining of biopsy specimens obtained from the major duodenal papilla might be useful to support the diagnosis of AIP[8,26,27,30,31]. Hisa et al[32] reported a resected case of a lymphoplasmacytic granuloma with abundant IgG4-positive plasma cells localized to the major duodenal papilla. The case was not associated with other IgG4-RD. This lesion is considered to be an IgG4-related pseudotumor localized to the major duodenal papilla.

IGG4-RELATED COLONIC LESIONS

Although infiltration of many IgG4-positive plasma cells is occasionally detected in the colonic mucosa of AIP patients, dense fibrosis or obliterative phlebitis was not observed in the lesion[1,5-7,21,33]. Although Ravi et al[34] suggested that inflammatory bowel disease might represent an extrapancreatic manifestation of AIP, in general, conventional AIP (type 1 AI) is rarely associated with ulcerative colitis (UC)[2,35]. IgG4-positive plasma cell infiltration is sometimes detected in the colonic mucosa of UC patients[36-40], but the mechanisms underlying IgG4-positive plasma cell infiltration in the colonic mucosa of UC patients are unknown. Matsui et al[41] reported a case of an AIP patient with a colonic polyp (ascending colon) containing many IgG4-positive plasma cells[42] who developed colonic polyposis (descending colon) containing many IgG4-positive plasma cells 1 year after complete remission of AIP with steroid therapy. The polyposis was markedly reduced with re-administration of steroids. They suggested that enhanced T helper type 2 responses to intestinal microflora may underlie the immunopathogenesis in patients with IgG4-RD[43]. Well-circumscribed sclerosing nodular lesions of the cecum and sigmoid colon composed of hyalinized fibrocollagenous tissue with abundant infiltration of IgG4-positive plasma cells were reported, and the two cases had no other IgG4-RD[21]. These polypoid or nodular lesions appear to be IgG4-related colonic lesions.

IGG4-RELATED INFLAMMATORY PSEUDOTUMOR OF AN ILEAL CONDUIT

An ill-defined, fibrotic, tumor-like mass, histologically showing fibrosis with infiltration of lymphocytes and IgG4-positive plasma cells and marked obliterative phlebitis, occurred in an ileal conduit created as part of surgery for urinary bladder cancer[44].

DISCUSSION

IgG4-RD shows organ enlargement or nodular lesions consisting of abundant infiltration of lymphocytes and IgG4-positive plasma cells and fibrosis in various organs simultaneously or metachronously[3,4]. The first International Symposium on IgG4-RD held in 2011 suggested that the term “IgG4-related disease” aptly recognizes the ubiquity of IgG4 within involved organs, and proposes a style that employs “IgG4-related” as a prefix to the organ system affected and pathological guidelines for the diagnosis of IgG4-RD[3,45]. The diagnosis of IgG4-RD rests on the combined presence of the characteristic histopathological appearances and increased number of IgG4-positive plasma cells. A histologically high suspicion of IgG4-RD requires the presence of at least two of three characteristic histological features including (1) dense lymphoplasmacytic infiltration; (2) fibrosis, usually storiform in character; and (3) obliterative phlebitis. The IgG4 counts required for the diagnosis differ among affected organs, ranging from 10 to 200 cells/hpf. The diagnosis of IgG4-RD requires considering both histopathological findings and clinical information such as elevated serum IgG4 levels, other organ involvement that is consistent with IgG4-RD, and effective response to steroid therapy[45].

Comprehensive clinical diagnostic criteria for IgG4-RD[4] were proposed in 2011. In the criteria, IgG4-RD is diagnosed when there is a characteristic diffuse/localized swelling or mass in a single or multiple organs with elevation of serum IgG4 levels or IgG4-related histological findings. However, the concept of IgG4-related gastrointestinal diseases was not included as objects of the criteria. It is unclear whether IgG4-related gastrointestinal diseases exist or what gastrointestinal lesions are regarded as IgG4-RD. To clarify these questions, this review of IgG4-related gastrointestinal diseases, the first of its kind, was conducted.

Infiltration of many IgG4-positive plasma cells is detected in the gastric and colonic mucosa and the major duodenal papillae of some AIP patients, but none of the following are observed in these lesions: a mass-like formation; dense fibrosis; or obliterative phlebitis[5-10]. They cannot be diagnosed as gastrointestinal lesions involved in IgG4-RD, because, as in many other organ systems, increased IgG4-positive plasma cells do not mean the disease is one of the family members of IgG4-RD. At this point, both the clinical finding of mass forming and histological finding of abundant infiltration of IgG4-positive plasma cells with fibrosis would appear to be necessary to make the diagnosis of IgG4-related gastrointestinal diseases.

IgG4-related pseudotumors have been reported in several organs, such as the liver and lung[46-48]. On review of these papers, there appear to be two types of IgG4-related gastrointestinal disease. One is a gastrointestinal lesion showing marked thickening of the wall of the esophagus[11,12] and stomach[17,23,24], consisting of dense fibrosis with abundant infiltration of IgG4-positive plasma cells, which usually show submucosal spreading. The other is an IgG4-related pseudotumor occurring in gastrointestinal regions such as the stomach[18-22], colon[21,42], and major duodenal papilla[32], showing polypoid or mass-like lesions. We currently consider these lesions to be IgG4-related gastrointestinal diseases. However, this is the first review of a few cases of IgG4-related gastrointestinal diseases; further studies should be conducted to confirm this concept.

Most solitary IgG4-related gastrointestinal lesions that are not associated with other IgG4-RD appear to be difficult to diagnose. It is of utmost importance to rule out malignancy. However, these lesions may respond to steroid therapy. To avoid unnecessary resection, IgG4-related gastrointestinal diseases should be considered in the differential diagnosis.

CONCLUSION

The concept of IgG4-related gastrointestinal disease remains unclear due to its rarity. There appear to be some IgG4-related gastrointestinal lesions that present with a mass-like lesion consisting of abundant infiltration of IgG4-positive plasma cells and lymphocytes and fibrosis.

Footnotes

P- Reviewers Kawa S, Liu B, Zhang X S- Editor Zhai HH L- Editor O’Neill M E- Editor Li JY

References
1.  Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, Okamoto A, Egawa N, Nakajima H. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38:982-984.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Kamisawa T, Takuma K, Egawa N, Tsuruta K, Sasaki T. Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol. 2010;7:401-409.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 156]  [Cited by in F6Publishing: 144]  [Article Influence: 10.3]  [Reference Citation Analysis (0)]
3.  Stone JH, Khosroshahi A, Deshpande V, Chan JK, Heathcote JG, Aalberse R, Azumi A, Bloch DB, Brugge WR, Carruthers MN. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64:3061-3067.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 496]  [Cited by in F6Publishing: 522]  [Article Influence: 47.5]  [Reference Citation Analysis (0)]
4.  Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Yoshino T, Nakamura S, Kawa S. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Research Program of Intractable Disease provided by the Ministry of Health, Labor, and Welfare of Japan. Nihon Naika Gakkai Zasshi. 2012;101:795-804.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 244]  [Cited by in F6Publishing: 601]  [Article Influence: 50.1]  [Reference Citation Analysis (0)]
5.  Kamisawa T, Funata N, Hayashi Y, Tsuruta K, Okamoto A, Amemiya K, Egawa N, Nakajima H. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut. 2003;52:683-687.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 330]  [Cited by in F6Publishing: 353]  [Article Influence: 16.8]  [Reference Citation Analysis (0)]
6.  Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A, Hayashi Y, Funata N. Gastrointestinal findings in patients with autoimmune pancreatitis. Endoscopy. 2005;37:1127-1130.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 37]  [Cited by in F6Publishing: 39]  [Article Influence: 2.1]  [Reference Citation Analysis (0)]
7.  Deheragoda MG, Church NI, Rodriguez-Justo M, Munson P, Sandanayake N, Seward EW, Miller K, Novelli M, Hatfield AR, Pereira SP. The use of immunoglobulin g4 immunostaining in diagnosing pancreatic and extrapancreatic involvement in autoimmune pancreatitis. Clin Gastroenterol Hepatol. 2007;5:1229-1234.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 104]  [Cited by in F6Publishing: 97]  [Article Influence: 5.7]  [Reference Citation Analysis (0)]
8.  Yoon KW, Doo EH, Kim SW, Park JB. In situ recovery of lycopene during biosynthesis with recombinant Escherichia coli. J Biotechnol. 2008;135:291-294.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 71]  [Cited by in F6Publishing: 74]  [Article Influence: 4.6]  [Reference Citation Analysis (0)]
9.  Sepehr A, Mino-Kenudson M, Ogawa F, Brugge WR, Deshpande V, Lauwers GY. IgG4+ to IgG+ plasma cells ratio of ampulla can help differentiate autoimmune pancreatitis from other “mass forming” pancreatic lesions. Am J Surg Pathol. 2008;32:1770-1779.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 41]  [Cited by in F6Publishing: 44]  [Article Influence: 2.9]  [Reference Citation Analysis (0)]
10.  Leise MD, Smyrk TC, Takahashi N, Sweetser SR, Vege SS, Chari ST. IgG4-associated cholecystitis: another clue in the diagnosis of autoimmune pancreatitis. Dig Dis Sci. 2011;56:1290-1294.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 43]  [Cited by in F6Publishing: 44]  [Article Influence: 2.9]  [Reference Citation Analysis (0)]
11.  Lopes J, Hochwald SN, Lancia N, Dixon LR, Ben-David K. Autoimmune esophagitis: IgG4-related tumors of the esophagus. J Gastrointest Surg. 2010;14:1031-1034.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 39]  [Cited by in F6Publishing: 43]  [Article Influence: 3.1]  [Reference Citation Analysis (0)]
12.  Lee H, Joo M, Song TJ, Chang SH, Kim H, Kim YS, Ryoo JY. IgG4-related sclerosing esophagitis: a case report. Gastrointest Endosc. 2011;73:834-837.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 25]  [Cited by in F6Publishing: 31]  [Article Influence: 2.4]  [Reference Citation Analysis (0)]
13.  Boemer MR, Santos BM, Aguillar OM, Stopa MJ. [An alternative proposal for the scientific productivity of nurse practitioners]. Rev Esc Enferm USP. 1990;24:211-223.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 60]  [Cited by in F6Publishing: 62]  [Article Influence: 4.8]  [Reference Citation Analysis (0)]
14.  Shinji A, Sano K, Hamano H, Unno H, Fukushima M, Nakamura N, Akamatsu T, Kawa S, Kiyosawa K. Autoimmune pancreatitis is closely associated with gastric ulcer presenting with abundant IgG4-bearing plasma cell infiltration. Gastrointest Endosc. 2004;59:506-511.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 70]  [Cited by in F6Publishing: 76]  [Article Influence: 3.8]  [Reference Citation Analysis (0)]
15.  Uehara T, Hamano H, Kawa S, Sano K, Oki K, Kobayashi Y, Nagaya T, Akamatsu T, Kurozumi M, Fujinaga Y. Chronic gastritis in the setting of autoimmune pancreatitis. Am J Surg Pathol. 2010;34:1241-1249.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 32]  [Cited by in F6Publishing: 35]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
16.  Yoshiba M, Sekiyama K, Sugata F, Okamoto H, Yamamoto K, Yotsumoto S. Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment. Dig Dis Sci. 1992;37:1253-1259.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  Baez JC, Hamilton MJ, Bellizzi A, Mortelé KJ. Gastric involvement in autoimmune pancreatitis: MDCT and histopathologic features. JOP. 2010;11:610-613.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  Kaji R, Okabe Y, Ishida Y, Takedatsu H, Kawahara A, Aino H, Morimitsu Y, Maekawa R, Toyonaga A, Tsuruta O. Autoimmune pancreatitis presenting with IgG4-positive multiple gastric polyps. Gastrointest Endosc. 2010;71:420-422.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 26]  [Cited by in F6Publishing: 29]  [Article Influence: 2.1]  [Reference Citation Analysis (0)]
19.  Kim do H, Kim J, Park do H, Lee JH, Choi KD, Lee GH, Jung HY, Kim JH. Immunoglobulin G4-related inflammatory pseudotumor of the stomach. Gastrointest Endosc. 2012;76:451-452.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 24]  [Cited by in F6Publishing: 28]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
20.  Rollins KE, Mehta SP, O’Donovan M, Safranek PM. Gastric IgG4-Related Autoimmune Fibrosclerosing Pseudotumour: A Novel Location. ISRN Gastroenterol. 2011;2011:873087.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 27]  [Cited by in F6Publishing: 32]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
21.  Chetty R, Serra S, Gauchotte G, Märkl B, Agaimy A. Sclerosing nodular lesions of the gastrointestinal tract containing large numbers of IgG4 plasma cells. Pathology. 2011;43:31-35.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 45]  [Cited by in F6Publishing: 78]  [Article Influence: 6.0]  [Reference Citation Analysis (0)]
22.  Na KY, Sung JY, Jang JY, Lim SJ, Kim GY, Kim YW, Park YK, Lee JH. Gastric nodular lesion caused by IgG4-related disease. Pathol Int. 2012;62:716-718.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 21]  [Cited by in F6Publishing: 26]  [Article Influence: 2.6]  [Reference Citation Analysis (0)]
23.  Fujita T, Ando T, Sakakibara M, Hosoda W, Goto H. Refractory gastric ulcer with abundant IgG4-positive plasma cell infiltration: a case report. World J Gastroenterol. 2010;16:2183-2186.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in CrossRef: 33]  [Cited by in F6Publishing: 35]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
24.  Bateman AC, Sommerlad M, Underwood TJ. Chronic gastric ulceration: a novel manifestation of IgG4-related disease? J Clin Pathol. 2012;65:569-570.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 21]  [Cited by in F6Publishing: 25]  [Article Influence: 2.1]  [Reference Citation Analysis (0)]
25.  Anjiki H, Kamisawa T, Tabata T, Takuma K, Egawa N, Yamamoto T, Kuyama Y, Urita Y, Tando Y, Nakamura T. Gastric emptying in patients with autoimmune pancreatitis. Pancreas. 2011;40:1302-1306.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in F6Publishing: 2]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
26.  Kubota K, Iida H, Fujisawa T, Ogawa M, Inamori M, Saito S, Kakuta Y, Oshiro H, Nakajima A. Clinical significance of swollen duodenal papilla in autoimmune pancreatitis. Pancreas. 2007;35:e51-e60.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 31]  [Cited by in F6Publishing: 28]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
27.  Kim MH, Moon SH, Kamisawa T. Major duodenal papilla in autoimmune pancreatitis. Dig Surg. 2010;27:110-114.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 27]  [Cited by in F6Publishing: 24]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
28.  Sink JD, Comer PB, James PM, Loveland SR. Evaluation of catheter placement in the treatment of venous air embolism. Ann Surg. 1976;183:58-61.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3]  [Cited by in F6Publishing: 9]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
29.  Kamisawa T, Anjiki H, Egawa N. Disappearance of an ampullary pseudotumor after steroid therapy for autoimmune pancreatitis. Gastrointest Endosc. 2010;71:847-848; discussion 848.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in F6Publishing: 2]  [Article Influence: 0.1]  [Reference Citation Analysis (0)]
30.  Kamisawa T, Tu Y, Nakajima H, Egawa N, Tsuruta K, Okamoto A. Usefulness of biopsying the major duodenal papilla to diagnose autoimmune pancreatitis: a prospective study using IgG4-immunostaining. World J Gastroenterol. 2006;12:2031-2033.  [PubMed]  [DOI]  [Cited in This Article: ]
31.  Moon SH, Kim MH, Park do H, Song TJ, Eum J, Lee SS, Seo DW, Lee SK. IgG4 immunostaining of duodenal papillary biopsy specimens may be useful for supporting a diagnosis of autoimmune pancreatitis. Gastrointest Endosc. 2010;71:960-966.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 76]  [Cited by in F6Publishing: 104]  [Article Influence: 7.4]  [Reference Citation Analysis (0)]
32.  Hisa T, Ohkubo H, Shiozawa S, Ishigame H, Furutake M, Takamatsu M. Lymphoplasmacytic granuloma localized to the ampulla of Vater: an ampullary lesion of IgG4-related systemic disease? Gastrointest Endosc. 2008;68:1229-1232.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 6]  [Cited by in F6Publishing: 8]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
33.  Kamisawa T, Nakajima H, Egawa N, Funata N, Tsuruta K, Okamoto A. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy. Pancreatology. 2006;6:132-137.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 198]  [Cited by in F6Publishing: 197]  [Article Influence: 10.4]  [Reference Citation Analysis (0)]
34.  Ravi K, Chari ST, Vege SS, Sandborn WJ, Smyrk TC, Loftus EV. Inflammatory bowel disease in the setting of autoimmune pancreatitis. Inflamm Bowel Dis. 2009;15:1326-1330.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 108]  [Cited by in F6Publishing: 104]  [Article Influence: 6.9]  [Reference Citation Analysis (0)]
35.  Hart PA, Kamisawa T, Brugge WR, Chung JB, Culver EL, Czakó L, Frulloni L, Go VL, Gress TM, Kim MH. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut. 2012;Dec 11; Epub ahead of print.  [PubMed]  [DOI]  [Cited in This Article: ]
36.  Rebours V, Le Baleur Y, Cazals-Hatem D, Stefanescu C, Hentic O, Maire F, Bouhnik Y, Bedossa P, Hammel P, Ruszniewski P. Immunoglobulin G4 immunostaining of gastric, duodenal, or colonic biopsies is not helpful for the diagnosis of autoimmune pancreatitis. Clin Gastroenterol Hepatol. 2012;10:91-94.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 27]  [Cited by in F6Publishing: 56]  [Article Influence: 4.7]  [Reference Citation Analysis (0)]
37.  Strehl JD, Hartmann A, Agaimy A. Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J Clin Pathol. 2011;64:237-243.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 237]  [Cited by in F6Publishing: 232]  [Article Influence: 17.8]  [Reference Citation Analysis (0)]
38.  Kamisawa T, Tabata T, Kuwata G, Koichi K. Extraintestinal manifestations of inflammatory bowel disease: autoimmune pancreatitis and other IgG4-related conditions. Crohn’s disease and ulcerative colitis. New York: Springer 2012; 601-610.  [PubMed]  [DOI]  [Cited in This Article: ]
39.  Raina A, Yadav D, Regueiro M, Krasinskas AM, Saul MI, Sapienza DA, Binion DG, Hartman DJ. Mucosal IgG4 cell infiltration in ulcerative colitis is linked to disease activity and primary sclerosing cholangitis. Inflamm Bowel Dis. 2013;19:1232-1237.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 17]  [Cited by in F6Publishing: 17]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
40.  Imura J, Fujimori T. IgG4-related plasmacytic enteropathy mimicking ulcerative colitis. Int J Surg Pathol. 2012;20:59.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
41.  Matsui H, Watanabe T, Ueno K, Ueno S, Tsuji Y, Matsumura K, Nakatsuji M, Ueda Y, Chiba T. Colonic polyposis associated with autoimmune pancreatitis. Pancreas. 2009;38:840-842.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 8]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
42.  Ueno K, Watanabe T, Kawata Y, Gotoh T, Tsuji Y, Ida H, Tada S, Yazumi S, Chiba T. IgG4-related autoimmune pancreatitis involving the colonic mucosa. Eur J Gastroenterol Hepatol. 2008;20:1118-1121.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 17]  [Cited by in F6Publishing: 18]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
43.  Akitake R, Watanabe T, Zaima C, Uza N, Ida H, Tada S, Nishida N, Chiba T. Possible involvement of T helper type 2 responses to Toll-like receptor ligands in IgG4-related sclerosing disease. Gut. 2010;59:542-545.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 68]  [Cited by in F6Publishing: 71]  [Article Influence: 5.1]  [Reference Citation Analysis (0)]
44.  Kuroda Y, Fujioka M, Kurosawa K, Ohashi K. IgG4-related inflammatory pseudotumor of the ileal conduit. Pathol Int. 2011;61:47-48.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3]  [Cited by in F6Publishing: 4]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
45.  Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, Klöppel G, Heathcote JG, Khosroshahi A, Ferry JA. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181-1192.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1714]  [Cited by in F6Publishing: 1631]  [Article Influence: 135.9]  [Reference Citation Analysis (0)]
46.  Zen Y, Harada K, Sasaki M, Sato Y, Tsuneyama K, Haratake J, Kurumaya H, Katayanagi K, Masuda S, Niwa H. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol. 2004;28:1193-1203.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 424]  [Cited by in F6Publishing: 441]  [Article Influence: 22.1]  [Reference Citation Analysis (0)]
47.  Zen Y, Kitagawa S, Minato H, Kurumaya H, Katayanagi K, Masuda S, Niwa H, Fujimura M, Nakanuma Y. IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol. 2005;36:710-717.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 252]  [Cited by in F6Publishing: 197]  [Article Influence: 10.4]  [Reference Citation Analysis (0)]
48.  Tsuboi H, Inokuma S, Setoguchi K, Shuji S, Hagino N, Tanaka Y, Yoshida N, Hishima T, Kamisawa T. Inflammatory pseudotumors in multiple organs associated with elevated serum IgG4 level: recovery by only a small replacement dose of steroid. Intern Med. 2008;47:1139-1142.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 51]  [Cited by in F6Publishing: 58]  [Article Influence: 3.6]  [Reference Citation Analysis (0)]